Earlier Endpoints are Required for Hemorrhagic Shock Trials Among Severely Injured Patients
- PMID: 28207628
- PMCID: PMC5392160
- DOI: 10.1097/SHK.0000000000000788
Earlier Endpoints are Required for Hemorrhagic Shock Trials Among Severely Injured Patients
Abstract
Background: Choosing the appropriate endpoint for a trauma hemorrhage control trial can determine the likelihood of its success. Recent Phase 3 trials and observational studies have used 24-h and/or 30-day all-cause mortality as the primary endpoint and some have not used exception from informed consent (EFIC), resulting in multiple failed trials. Five recent high-quality prospective studies among 4,064 hemorrhaging trauma patients provide new evidence to support earlier primary endpoints.
Methods: The goal of this project was to determine the optimal endpoint for hemorrhage control trials using existing literature and new analyses of previously published data.
Results: Recent studies among bleeding trauma patients show that hemorrhagic deaths occur rapidly, at a high rate, and in a consistent pattern. Early preventable deaths among trauma patients are largely due to hemorrhage and the median time to hemorrhagic death from admission is 2.0 to 2.6 h. Approximately 85% of hemorrhagic deaths occur within 6 h. The hourly mortality rate due to traumatic injury decreases rapidly after enrollment from 4.6% per hour at 1 hour postenrollment to 1% per hour at 6 h to <0.1% per hour by 9 h and thereafter. Early primary endpoints (within 6 h) have critically important benefits for hemorrhage control trials, including being congruent with the median time to hemorrhagic death, biologic plausibility, and enabling the use of all-cause mortality, which is definitive and objective.
Conclusions: Primary endpoints should be congruent with the timing of the disease process. Therefore, if a resuscitation/hemorrhage control intervention is under study, a primary endpoint of all-cause mortality evaluated within the first 6 h is appropriate. Before choosing the timing of the primary endpoint for a large multicenter trial, we recommend performing a Phase 2 trial under EFIC to better understand the effects of the hemorrhage control intervention and distribution of time to death. When early primary endpoints are used, patients should be monitored for multiple subsequent secondary safety endpoints, including 24 h and 30-day all-cause mortality as well as the customary safety endpoints.
Figures





Similar articles
-
Outcomes of traumatic hemorrhagic shock and the epidemiology of preventable death from injury.Transfusion. 2019 Apr;59(S2):1423-1428. doi: 10.1111/trf.15161. Transfusion. 2019. PMID: 30980749 Review.
-
The informed consent process and the use of the exception to informed consent in the clinical trial of diaspirin cross-linked hemoglobin (DCLHb) in severe traumatic hemorrhagic shock. DCLHb Traumatic Hemorrhagic Shock study group.Acad Emerg Med. 1999 Dec;6(12):1203-9. doi: 10.1111/j.1553-2712.1999.tb00134.x. Acad Emerg Med. 1999. PMID: 10609921 Clinical Trial.
-
Rational and design of the T-STORHM Study: A prospective randomized trial comparing fresh whole blood to blood components for acutely bleeding trauma patients.Transfus Clin Biol. 2019 Nov;26(4):198-201. doi: 10.1016/j.tracli.2019.09.004. Epub 2019 Oct 1. Transfus Clin Biol. 2019. PMID: 31645305
-
Prehospital Blood Product and Crystalloid Resuscitation in the Severely Injured Patient: A Secondary Analysis of the Prehospital Air Medical Plasma Trial.Ann Surg. 2021 Feb 1;273(2):358-364. doi: 10.1097/SLA.0000000000003324. Ann Surg. 2021. PMID: 30998533 Clinical Trial.
-
A Practical Guide to Trauma Resuscitation - Recommendations for Managing Hemorrhagic Shock in the Rural Healthcare Setting.S D Med. 2022 Oct;75(10):469-471. S D Med. 2022. PMID: 36889273 Review.
Cited by
-
Whole blood transfusion versus component therapy in trauma resuscitation: a systematic review and meta-analysis.J Am Coll Emerg Physicians Open. 2020 May 29;1(4):633-641. doi: 10.1002/emp2.12089. eCollection 2020 Aug. J Am Coll Emerg Physicians Open. 2020. PMID: 33000082 Free PMC article.
-
Prehospital plasma in injured patients is associated with survival principally in blunt injury: Results from two randomized prehospital plasma trials.J Trauma Acute Care Surg. 2020 Jan;88(1):33-41. doi: 10.1097/TA.0000000000002485. J Trauma Acute Care Surg. 2020. PMID: 31524836 Free PMC article.
-
Characteristics of traumatic major haemorrhage in a tertiary trauma center.Scand J Trauma Resusc Emerg Med. 2024 Mar 25;32(1):24. doi: 10.1186/s13049-024-01196-z. Scand J Trauma Resusc Emerg Med. 2024. PMID: 38528572 Free PMC article.
-
Dried Plasma for Major Trauma: Past, Present, and Future.Life (Basel). 2024 May 10;14(5):619. doi: 10.3390/life14050619. Life (Basel). 2024. PMID: 38792640 Free PMC article. Review.
-
RBC Transfusion Strategies in the ICU: A Concise Review.Crit Care Med. 2019 Nov;47(11):1637-1644. doi: 10.1097/CCM.0000000000003985. Crit Care Med. 2019. PMID: 31449062 Free PMC article. Review.
References
-
- National Academies of Sciences, Engineering, and Medicine . A national trauma care system: Integrating military and civilian trauma systems to achieve zero preventable deaths after injury. The National Academies Press; Washington, DC: 2016. - PubMed
-
- Norton R, Kobusingye O. Injuries. N Engl J Med. 2013;368(18):1723–1730. - PubMed
-
- Rhee P, Joseph B, Pandit V, Aziz H, Vercruysse G, Kulvatunyou N, Friese RS. Increasing trauma deaths in the United States. Ann Surg. 2014;260(1):13–21. - PubMed
-
- Kwon AM, Garbett NC, Kloecker GH. Pooled preventable death rates in trauma patients : Meta analysis and systematic review since 1990. Eur J Trauma Emerg Surg. 2014;40(3):279–285. - PubMed
-
- Holcomb JB, Weiskopf R, Champion H, Gould SA, Sauer RM, Brasel K, Bochicchio G, Bulger E, Cotton BA, Davis D, et al. Challenges to effective research in acute trauma resuscitation: consent and endpoints. Shock. 2011;35(2):107–113. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical